Regeneron Pharmaceuticals (REGN) Buildings (2010 - 2017)

Regeneron Pharmaceuticals' Buildings history runs 6 years deep, the most recent figure standing at $1.4 billion for Q4 2017.

• In Q4 2017, Buildings rose 12.77% year-over-year to $1.4 billion; the TTM figure through Dec 2017 stood at $1.4 billion (up 12.77% YoY), while the FY2017 annual figure was $1.4 billion, up 12.77% from the prior year.
• Buildings for Q4 2017 stood at $1.4 billion, up from $1.3 billion in the prior quarter.
• The five-year high for Buildings was $1.4 billion in Q4 2017, with the low at $343.4 million in Q4 2013.
• The 5-year median for Buildings is $760.5 million (2015), against an average of $844.5 million.
• The sharpest annual moves came in 2015 and 2017: Buildings jumped 90.61% in 2015, then grew 12.77% in 2017.
• Regeneron Pharmaceuticals' Buildings stood at $343.4 million in 2013, then climbed by 16.2% to $399.0 million in 2014, then surged by 90.61% to $760.5 million in 2015, then soared by 68.08% to $1.3 billion in 2016, then increased by 12.77% to $1.4 billion in 2017.
• Business Quant data shows REGN's Buildings at $1.4 billion in Q4 2017, $1.3 billion in Q4 2016, and $760.5 million in Q4 2015.